Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Evaluate wide market index fund performance against the SP 500 in retirement planning, emphasizing return consistency and fee impact.
28,313 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
As affordability remains stressed and sales slow, seasoned real estate agents guide buyers and sellers through one of...
A surprising all-stock deal sent ON Semiconductor lower, wiping out gains from a strong AI data center narrative. Her...
June payroll gains undershot forecasts, with revisions cooling prior months and participation slipping. The report le...
Fresh data suggests U.S. home prices may have found a floor. As affordability stabilizes, demand returns and lenders ...
A UK-listed bitcoin treasury company uncovers a counterintuitive edge: buying back its own stock can yield about 24% ...
A stock trading earnings at a strikingly low multiple sits quietly in many portfolios. This article breaks down how t...
Micron shares slid about 4% in early trading even after the company posted a robust quarterly report and raised its f...
The MLS/CLAW announces a sweeping tweak to its IDX policy and will add Compass’s full active listings, aiming to boos...
Broker Public Portal and Realtors Property Resource unveiled a staged integration of the Realtors Valuation Model int...
Toll Brothers raises its 2026 delivery guidance on persistent luxury demand and better-than-expected absorption. The ...
Rachel Glazer is rejoining Brown Harris Stevens from Compass, bringing her team and more than $1 billion in career sa...